ACRP CP CERTIFICATION EXAM LATEST 2026-2027 ACTUAL EXAM
WITH COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS
(100% VERIFIED ANSWERS) |ALREADY GRADED A+| ||PROFESSOR
VERIFIED|| ||BRANDNEW!!!||
A medical student is approached by a faculty member for possible
participation in a cricothyroidotomy simulation research study.
Which of the following increases risk to the subject? - ANSWER-
Consenting in the presence of figure of authority
What would be the first priority for an investigator when a subject
wishes to withdraw prematurely from the trial? - ANSWER-Try to
obtain the subject's reason for withdrawal.
A blood sample collection is required to screen for bloodborne
pathogens before subject could be enrolled in a study. Where will
subjects find information of the procedures and any foreseeable
risks or inconveniences? - ANSWER-ICF
Per ICH: an IRB/IEC must keep correspondence for at least how
long after the completion of a clinical trial? - ANSWER-3 years
,2|Page
A CRA notices during an onsite visit that the date on IRB/IEC
approval letter for a protocol is prior to the effective date indicated
on the cover page of the protocol and the signatures of the
investigator and sponsor. What should the CRA do FIRST? -
ANSWER-Confirm dates of initial receipt of the sponsor protocol
and the IRB/IEC submission dates.
A CRO recently switched from paper CRF to an EDC system. The
EDC system must conform to the established requirements for -
ANSWER-validation, accuracy, reliability, and completeness.
When should a research study involving human subjects be
registered in a publicly accessible database? - ANSWER-Before
recruiting the first subject
An unconscious adult subject was enrolled in a study after
obtaining consent from an LAR: and protocol therapy was
initiated. The subject showed significant improvement in his
clinical condition: and regained consciousness. The Investigator
should inform the subject about the study and - ANSWER-obtain
consent from the subject for the study.
,3|Page
After completion of a study: the final trial close-out monitoring
report prepared by the CRA should be filed in which of the
following stakeholder files? - ANSWER-The sponsor's files
A site is in the start-up phase of an industry-sponsored phase 3
trial: and has received IRB/IEC approval. The site can begin
enrolling subjects after - ANSWER-a signed clinical trial
agreement between the site and sponsor is in place.
In a multi-arm: randomized clinical trial: one arm of the protocol
was terminated due to an increased risk of breast cancer in the
subjects. Who is responsible for providing a written report to the
IRB/IEC? - ANSWER-PI
Part of a sponsor's responsibility pertaining to electronic trial data
handling is to maintain an audit trail: data trail: and edit trail.
Which entity is primarily charged with considering subject rights
and well-being during clinical trials? - ANSWER-Institutional
Review Board (IRB)/Independent Ethics Committee (IEC)
, 4|Page
Which of the following would be considered a vulnerable
population requiring special consideration by an IRB/IEC? -
ANSWER-1. Medical, pharmacy, dental, and nursing students:
2. Prisoners
3. Serving military personnel
T or F- The terms "serious" and "severe" are synonymous
according to ICH - ANSWER-False
An Unexpected Adverse drug reaction is - ANSWER-A reaction
that is not consistent with the applicable product information
ICH safety definitions can be found in - ANSWER-ICH E2A
An Adverse Event (AE) that is severe in intensity - ANSWER-May
not meet the definition of serious
T or F- Information discovered during the course of a clinical
investigation that might materially influence the benefit-risk